« Previous
Next »
Fertility and Sterility
Volume 93, Issue 1
, Pages 174-183
, 1 January 2010
Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women
References
- . Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91:760–771
- . Ovulation induction: clomiphene citrate. In: Adashi EY, Rock JA, Rosenwaks Z editor. Reproductive endocrinology, surgery and technology. Lippencott-Raven: Philadelphia, PA; 1996;1:1181–1206
- . Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–477
- . The effect of clomiphene citrate and tamoxifen on cervical mucus. Acta Obstet Gynecol Scand. 1988;67:311–314
- . The effects of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm–cervical mucus interaction in ovulatory women. Hum Reprod. 1993;8:437–441
- . Clomiphene citrate—end of an era? A mini-review. Hum Reprod. 2005;8:2043–2051
- . Ovulation induction in perspective. Hum Reprod Update. 2002;8:449–462
- Case series of a single centre's treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination in 2002. Aust N Z J Obstet Gynaecol. 2004;44:156–159
- . Risk of multiple gestation after ovulation induction in polycystic ovary syndrome. J Reprod Med. 2007;52:896–900
- Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos. 2001;22:191–197
- . Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol. 2000;10:244–247
- . A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82:1561–1563
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005;84:82–87
- . Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril. 2005;83:110–115
- . A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril. 2002;78:280–285
- . Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online. 2003;7:543–546
- . Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril. 2007;56:208–212
- . Effects of letrozole on superovulation with gonadotrophins in women undergoing intrauterine insemination. Fertil Steril. 2003;80:1325–1329
- . Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Hum Reprod. 2006;21:2593–2600
- . The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment. Reprod Biol Endocrinol. 2005;3:54
- Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab. 1998;83:2479–2485
- . Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod. 2003;18:1588–1597
- . Associate editor's commentary: the dawning of the non-cancer uses of aromatase inhibitors in gynaecology. Hum Reprod. 2003;8:1598–1602
- Changes in pituitary sensitivity to GnRH in estrogen treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role. Hum Reprod. 2004;19:1985–1992
- . Are estrogens of importance to primate/human ovarian folliculogenesis?. Endocrinol Rev. 2001;22:389–424
- . Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole). J Assist Reprod Genet. 2006;23:407–412
- Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. Ann Oncol. 2002;13:1059–1066
P.R.J. has nothing to disclose. R.S.P. has nothing to disclose.
PII: S0015-0282(08)04136-8
doi: 10.1016/j.fertnstert.2008.10.009
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 93, Issue 1
, Pages 174-183
, 1 January 2010

